Cargando…

Free triiodothyronine and global registry of acute coronary events risk score on predicting long-term major adverse cardiac events in STEMI patients undergoing primary PCI

BACKGROUND: The aim of this study is to investigate the combined value of fT3 and GRACE risk score for cardiovascular prognosis in ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI). METHODS: Three hundred and thirty eight patients with STE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Xuewei, Zhang, Shouyan, Zhang, Mingming, Wang, Hao, Fan, Caifeng, Gu, Yunfei, Wei, Jinghan, Qiu, Chunguang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182867/ https://www.ncbi.nlm.nih.gov/pubmed/30309366 http://dx.doi.org/10.1186/s12944-018-0881-7

Ejemplares similares

Combined value of red blood cell distribution width and global registry of acute coronary events risk score on predicting long-term major adverse cardiac events in STEMI patients undergoing primary PCI
por: Chang, Xue-Wei, et al.
Publicado: (2018)

Risk factors and prediction nomogram model for 1-year readmission for major adverse cardiovascular events in patients with STEMI after PCI
por: Yao, Wensen, et al.
Publicado: (2022)

Plasma DPP4 activity is associated with no-reflow and major bleeding events in Chinese PCI-treated STEMI patients
por: Li, Jing Wei, et al.
Publicado: (2016)

Post-operative blood pressure and 3-year major adverse cardiac events in Chinese patients undergoing PCI
por: Gan, Lijun, et al.
Publicado: (2021)

Relationships between circulating branched chain amino acid concentrations and risk of adverse cardiovascular events in patients with STEMI treated with PCI
por: Du, Xiaoyu, et al.
Publicado: (2018)

Will intravenous paracetamol crush fentanyl in patients undergoing PCI for STEMI?
por: ten Berg, J. M., et al.
Publicado: (2019)

Effect of prehospital treatment in STEMI patients undergoing primary PCI
por: Fabris, Enrico, et al.
Publicado: (2022)

Retraction Note: Post-operative blood pressure and 3-year major adverse cardiac events in chinese patients undergoing PCI
por: Gan, Lijun, et al.
Publicado: (2023)

Rescue PCI in the management of STEMI: Contemporary results from the Melbourne Interventional Group registry()
por: Fernando, Himawan, et al.
Publicado: (2021)

Role of tirofiban with dual antiplatelet therapy in patients with STEMI undergoing primary PCI
por: Türker, Yasin
Publicado: (2016)

Complementary Pharmacotherapy for STEMI Undergoing Primary PCI: An Evidence-Based Clinical Approach
por: Fabris, Enrico, et al.
Publicado: (2022)

Acute Response in the Noninfarcted Myocardium Predicts Long-Term Major Adverse Cardiac Events After STEMI
por: Shanmuganathan, Mayooran, et al.
Publicado: (2023)

Comparison of RISK-PCI, GRACE, TIMI risk scores for prediction of major adverse cardiac events in patients with acute coronary syndrome
por: Jakimov, Tamara, et al.
Publicado: (2017)

The effects of tirofiban infusion on clinical and angiographic outcomes of patients with STEMI undergoing primary PCI
por: Kaymaz, Cihangir, et al.
Publicado: (2016)

Impact of COVID-19 pandemic on STEMI undergoing primary PCI treatment in Beijing, China
por: Gong, Xuhe, et al.
Publicado: (2022)

Dynamic changes of monocytes subsets predict major adverse cardiovascular events and left ventricular function after STEMI
por: Boidin, Maxime, et al.
Publicado: (2023)

Using the RISK-PCI Score in the Long-Term Prediction of Major Adverse Cardiovascular Events and Mortality after Primary Percutaneous Coronary Intervention
por: Savic, Lidija, et al.
Publicado: (2019)

Incidence, delays, and outcomes of STEMI during COVID‐19 outbreak: Analysis from the France PCI registry
por: Rangé, Grégoire, et al.
Publicado: (2020)

Predictors of ST Depression Resolution in STEMI Patients Undergoing Primary PCI and Its Clinical Significance
por: Ghaffari, Samad, et al.
Publicado: (2020)

Does Opioid Addiction Influence Clinical and Angiographic Outcomes in STEMI Patients Undergoing Emergency PCI?
por: Amirpour, Afshin, et al.
Publicado: (2023)

Index of microcirculatory resistance predicts long term cardiac systolic function in patients with STEMI undergoing primary PCI
por: Qi, Yu, et al.
Publicado: (2021)

High Bolus Tirofiban vs Abciximab in Acute STEMI Patients Undergoing Primary PCI – The Tamip Study
por: Balghith, Mohammed A.
Publicado: (2012)

Assessment of Growth Differentiation Factor 15 Levels on Coronary Flow in Patients with STEMI Undergoing Primary PCI
por: Dogdu, Orhan
Publicado: (2020)

Clinical characteristics of patients with premature acute coronary syndrome and adverse cardiovascular events after PCI
por: Shi, Xiao-Jun, et al.
Publicado: (2019)

Elevated serum FGF21 predicts the major adverse cardiovascular events in STEMI patients after emergency percutaneous coronary intervention
por: Gu, Lingyun, et al.
Publicado: (2021)

New guidelines on primary PCI for patients with STEMI: changing insights
por: van der Wall, E.E.
Publicado: (2015)

Impact of Smoking Status on Mortality in STEMI Patients Undergoing Mechanical Reperfusion for STEMI: Insights from the ISACS–STEMI COVID-19 Registry
por: De Luca, Giuseppe, et al.
Publicado: (2022)

Serious Adverse Events in the Canadian Registry of Children Receiving Palivizumab (CARESS) for Respiratory Syncytial Virus Prevention
por: Chen, Jinghan Jenny, et al.
Publicado: (2015)

Outcome of manual thrombus aspiration for patients undergoing primary PCI for acute STEMI showing large thrombus burden
por: Elfekky, Ehab Mohamed, et al.
Publicado: (2021)

Effects of opium use on one-year major adverse cardiovascular events (MACE) in the patients with ST-segment elevation MI undergoing primary PCI: a propensity score matched - machine learning based study
por: Jenab, Yaser, et al.
Publicado: (2023)

Time to Treatment and In-Hospital Major Adverse Cardiac Events Among Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention (PCI) According to the 24/7 Primary PCI Service Registry in Iran: Cross-Sectional Study
por: Nozari, Younes, et al.
Publicado: (2020)

Effect of Chinese national holidays and weekends versus weekday admission on clinical outcomes in patients with STEMI undergoing primary PCI
por: Tang, Liang, et al.
Publicado: (2017)

Comparison of HEAR and HEART Scores for Major Adverse Cardiovascular Events
por: Uyan, Umut
Publicado: (2023)

Low Free Triiodothyronine Level as a Predictor of Cardiovascular Events and All-Cause Mortality in Patients Undergoing Hemodialysis: The DREAM Cohort
por: Yamazaki, Yuko, et al.
Publicado: (2021)

Can Exercise Capacity Assessed by the 6 Minute Walk Test Predict the Development of Major Adverse Cardiac Events in Patients with STEMI after Fibrinolysis?
por: Hassan, Ayman K. M., et al.
Publicado: (2014)

The abnormal level and prognostic potency of multiple inflammatory cytokines in PCI‐treated STEMI patients
por: Zhang, Jing, et al.
Publicado: (2022)

Biomaker evaluation for major adverse cardiovascular event development in patients undergoing cardiac Surgery
por: Imperiali, Claudia E., et al.
Publicado: (2020)

The prognostic utility of GRACE risk score in predictive cardiovascular event rate in STEMI patients with successful fibrinolysis and delay intervention in non PCI-capable hospital: a retrospective cohort study
por: Chotechuang, Yotsawee, et al.
Publicado: (2016)

High levels of interleukin-6 are associated with final infarct size and adverse clinical events in patients with STEMI
por: Tøllefsen, Ingvild Maria, et al.
Publicado: (2021)

Impact of periprocedural morphine use on mortality in STEMI patients treated with primary PCI
por: Domokos, Dominika, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hu2bupvo2gsd81anc3o3jtvmn9